Back to Resource Hub Article

How to Run a Successful Decentralized Oncology Trial

Oncology research, especially decentralized oncology trials, continue to undergo rapid transformation, driven by a number of factors including:

  • Increased interest in understanding the patient experience beyond health-related, quality-of-life measures
  • Regulatory guidance updates
  • Rapid acceptance of digital solutions such as telehealth and digital health technologies

Learn from Signant’s in-house clinical science and eCOA experts how researchers can take advantage of these new paradigms in clinical research to run more efficient, inclusive, and convenient oncology trials.

This article is taken from International Clinical Trials February 2022, pages 34-36 ©️ Samedan Ltd

Similar posts

Looking for more insights? Explore related resources.

CASE STUDY

Signant’s Rapid eConsent Implementation Contributes to the Advancement of DCTs in Japan

READ THE STUDY
WHITE PAPER

Takeaways and Perspectives: FDA Draft Guidance on DCTs

READ THE PAPER
ARTICLE

eCOA and the DCT Slope of Enlightenment

READ THE ARTICLE

Get notified on new marketing insights

Here mention the benefits of subscribing